Consensus LeMaitre Vascular, Inc.

Equities

LMAT

US5255582018

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
65.46 ^USD	+3.92%		+3.48%	+15.33%

Apr. 26	Stifel Upgrades LeMaitre Vascular to Buy From Hold, Adjusts Price Target to $75 From $59	MT
Mar. 12	Lemaitre Vascular Insider Sold Shares Worth $309,684, According to a Recent SEC Filing	MT

Evolution of the average Target Price on LeMaitre Vascular, Inc.

Price target over the last 5 years

History of analyst recommendation changes

5fbba91e9e9353e.LjlTe3s_yp7MwhMC2TzcThPC1C_zYsWa338l2usJpNQ.XkswGgNVqOuamkNugWOUHHypg1inKJfYmBVM97F5iZ5DTwQZLlGcy4C3Xg~85cd9a308b3245b6dffa962bd99cb136

Analyst Recommendations on LeMaitre Vascular, Inc.

Stifel Upgrades LeMaitre Vascular to Buy From Hold, Adjusts Price Target to $75 From $59	Apr. 26	MT
Barrington Raises Price Target on LeMaitre Vascular to $69 From $66, Keeps Outperform Rating	Feb. 28	MT
JMP Securities Initiates LeMaitre Vascular With Market Outperform Rating, Price Target is $60	23-10-23	MT
Oppenheimer Initiates Coverage on LeMaitre Vascular With Outperform Rating, $70 Price Target	23-09-06	MT
Jefferies Downgrades LeMaitre Vascular to Hold From Buy, Adjusts Price Target to $67 From $63	23-08-03	MT
Barrington Raises Price Target on LeMaitre Vascular to $66 From $62, Maintains Outperform Rating	23-08-02	MT
Stifel Raises LeMaitre Vascular's Price Target to $60 From $48, Hold Rating Kept	23-05-03	MT
Jefferies Raises LeMaitre Vascular's Price Target to $63 From $57, Maintains Buy Rating	23-05-03	MT
Roth MKM Raises LeMaitre Vascular's Price Target to $54 From $48, Neutral Rating Kept	23-05-03	MT
Barrington Research Upgrades LeMaitre Vascular to Outperform From Market Perform	23-05-03	MT
Barrington Research Downgrades LeMaitre Vascular to Market Perform From Outperform	22-10-28	MT
Barrington Lowers LeMaitre Vascular's Price Target to $50 From $54, Maintains Outperform Rating	22-04-29	MT
Barrington Research Trims LeMaitre Vascular's Price Target to $54 From $62, Maintains Outperform Rating	22-02-25	MT
Barrington Adjusts Price Target on LeMaitre Vascular to $62 From $64, Maintains Outperform Rating	21-10-29	MT
LEMAITRE VASCULAR : Jefferies Initiates LeMaitre Vascular at Buy Rating With $70 Price Target	21-09-16	MT
LEMAITRE VASCULAR : Roth Capital Adjusts LeMaitre Vascular's Price Target to $58 from $55, Keeps Neutral Rating	21-08-03	MT
LEMAITRE VASCULAR : Barrington Adjusts Price Target on LeMaitre Vascular to $64 From $59, Maintains Outperform Rating	21-07-30	MT
LEMAITRE VASCULAR : Roth Capital Adjusts LeMaitre Vascular PT to $55 From $53, Maintains Neutral Rating	21-05-04	MT
LEMAITRE VASCULAR : Barrington Adjusts Price Target on LeMaitre Vascular to $59 From $49, Maintains Outperform Rating	21-04-30	MT
LEMAITRE VASCULAR : Barrington Adjusts LeMaitre Vascular PT to $49 From $47, Maintains Outperform Rating	21-02-26	MT
LEMAITRE VASCULAR : KeyBanc Starts LeMaitre Vascular at Sector Weight	21-02-12	MT
LEMAITRE VASCULAR : Barrington Research Adjusts Price Target on LeMaitre Vascular to $47 From $46, Keeps Outperform Rating	20-12-14	MT
LEMAITRE VASCULAR : Roth Capital Adjusts LeMaitre Vascular PT to $36 From $32, Maintains Neutral Rating	20-10-30	MT